Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Piezophototronic gated optofluidic logic computations empowering intrinsic reconfigurable switches.

Purusothaman Y, Alluri NR, Chandrasekhar A, Venkateswaran V, Kim SJ.

Nat Commun. 2019 Sep 26;10(1):4381. doi: 10.1038/s41467-019-12148-y.

2.

Functional validation of metabolic genes that distinguish Gleason 3 from Gleason 4 prostate cancer foci.

Roberto D, Selvarajah S, Park PC, Berman D, Venkateswaran V.

Prostate. 2019 Nov;79(15):1777-1788. doi: 10.1002/pros.23903. Epub 2019 Sep 10.

PMID:
31503357
3.

Evolutionary dynamics of complex multiple games.

Venkateswaran VR, Gokhale CS.

Proc Biol Sci. 2019 Jun 26;286(1905):20190900. doi: 10.1098/rspb.2019.0900. Epub 2019 Jun 26.

4.

Combining Desmopressin and Docetaxel for the Treatment of Castration-Resistant Prostate Cancer in an Orthotopic Model.

Bass R, Roberto D, Wang DZ, Cantu FP, Mohamadi RM, Kelley SO, Klotz L, Venkateswaran V.

Anticancer Res. 2019 Jan;39(1):113-118. doi: 10.21873/anticanres.13086.

PMID:
30591447
5.

Resource dispersion influences dispersal evolution of highly insulated insect communities.

Venkateswaran V, Kumble ALK, Borges RM.

Biol Lett. 2018 Oct 31;14(10). pii: 20180111. doi: 10.1098/rsbl.2018.0111.

6.
7.

AMBU® LMA® in Children With Cleft Palate for Ophthalmic Surgery: A Case Report.

Goswami D, Chowdhury AR, Venkateswaran V, Sunkesula SG, Kundu R.

A A Pract. 2019 Feb 15;12(4):109-111. doi: 10.1213/XAA.0000000000000859.

PMID:
30095444
8.

Total energy expenditure and vigorous-intensity physical activity are associated with reduced odds of reclassification among men on active surveillance.

Guy DE, Vandersluis A, Klotz LH, Fleshner N, Kiss A, Parker C, Venkateswaran V.

Prostate Cancer Prostatic Dis. 2018 Jun;21(2):187-195. doi: 10.1038/s41391-017-0010-0. Epub 2017 Dec 14.

PMID:
29242596
9.

Life-history strategy, resource dispersion and phylogenetic associations shape dispersal of a fig wasp community.

Venkateswaran V, Shrivastava A, Kumble ALK, Borges RM.

Mov Ecol. 2017 Dec 6;5:25. doi: 10.1186/s40462-017-0117-x. eCollection 2017.

10.
11.

Primary Hyperoxaluria Type 1 with Homozygosity for a Double-mutated AGXT Allele in a 2-year-old Child.

Krishnamurthy S, Kartha GB, Venkateswaran VS, Prasannakumar M, Mahadevan S, Gowda M, Pelle A, Giachino D.

Indian J Nephrol. 2017 Sep-Oct;27(5):402-405. doi: 10.4103/ijn.IJN_261_16.

12.

The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer.

Mayer MJ, Klotz LH, Venkateswaran V.

J Urol. 2017 Apr;197(4):1068-1075. doi: 10.1016/j.juro.2016.10.069. Epub 2016 Oct 28.

PMID:
27984108
13.

Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance.

Zhao F, Olkhov-Mitsel E, van der Kwast T, Sykes J, Zdravic D, Venkateswaran V, Zlotta AR, Loblaw A, Fleshner NE, Klotz L, Vesprini D, Bapat B.

J Urol. 2017 Feb;197(2):335-341. doi: 10.1016/j.juro.2016.08.081. Epub 2016 Aug 18.

PMID:
27545574
14.

Severe Hyponatremia Complicating Urinary Tract Malformation with Pyelonephritis.

Krishamurthy S, Venkateswaran VS.

Indian Pediatr. 2016 Oct 8;53(10):928. No abstract available.

15.

Brainstem micro-abscesses caused by Burkholderia pseudomallei in a 10-month-old infant: a case report.

Prasanna Kumar M, Krishnamurthy S, Venkateswaran VS, Mahadevan S, Lalitha M, Sistla S, Nagarajan K.

Paediatr Int Child Health. 2017 Aug;37(3):230-232. doi: 10.1080/20469047.2016.1198560. Epub 2016 Jul 4.

PMID:
27376438
16.

The role of lifestyle characteristics on prostate cancer progression in two active surveillance cohorts.

Vandersluis AD, Guy DE, Klotz LH, Fleshner NE, Kiss A, Parker C, Venkateswaran V.

Prostate Cancer Prostatic Dis. 2016 Sep;19(3):305-10. doi: 10.1038/pcan.2016.22. Epub 2016 Jun 28.

PMID:
27349497
17.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M.

Semin Cancer Biol. 2015 Dec;35 Suppl:S276-S304. doi: 10.1016/j.semcancer.2015.09.007. Review.

18.

Metformin and prostate cancer stem cells: a novel therapeutic target.

Mayer MJ, Klotz LH, Venkateswaran V.

Prostate Cancer Prostatic Dis. 2015 Dec;18(4):303-9. doi: 10.1038/pcan.2015.35. Epub 2015 Jul 28. Review.

PMID:
26215782
19.

A combination of desmopressin and docetaxel inhibit cell proliferation and invasion mediated by urokinase-type plasminogen activator (uPA) in human prostate cancer cells.

Sasaki H, Klotz LH, Sugar LM, Kiss A, Venkateswaran V.

Biochem Biophys Res Commun. 2015 Aug 28;464(3):848-54. doi: 10.1016/j.bbrc.2015.07.050. Epub 2015 Jul 13.

PMID:
26182875
20.

Capsaicin reduces the metastatic burden in the transgenic adenocarcinoma of the mouse prostate model.

Venier NA, Yamamoto T, Sugar LM, Adomat H, Fleshner NE, Klotz LH, Venkateswaran V.

Prostate. 2015 Sep;75(12):1300-11. doi: 10.1002/pros.23013. Epub 2015 Jun 5.

PMID:
26047020
21.

The effects of serum from prostate cancer patients with elevated body mass index on prostate cancer cells in vitro.

Mora BC, Fleshner NE, Klotz LH, Venkateswaran V.

Lipid Insights. 2015 Apr 19;8:11-9. doi: 10.4137/LPI.S23135. eCollection 2015.

22.

Cancer prevention and therapy through the modulation of the tumor microenvironment.

Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, Crawford S, Fujii H, Georgakilas AG, Guha G, Halicka D, Helferich WG, Heneberg P, Honoki K, Keith WN, Kerkar SP, Mohammed SI, Niccolai E, Nowsheen S, Vasantha Rupasinghe HP, Samadi A, Singh N, Talib WH, Venkateswaran V, Whelan RL, Yang X, Felsher DW.

Semin Cancer Biol. 2015 Dec;35 Suppl:S199-S223. doi: 10.1016/j.semcancer.2015.02.007. Epub 2015 Apr 10. Review.

23.

T-cell Expression of IL10 Is Essential for Tumor Immune Surveillance in the Small Intestine.

Dennis KL, Saadalla A, Blatner NR, Wang S, Venkateswaran V, Gounari F, Cheroutre H, Weaver CT, Roers A, Egilmez NK, Khazaie K.

Cancer Immunol Res. 2015 Jul;3(7):806-14. doi: 10.1158/2326-6066.CIR-14-0169. Epub 2015 Apr 8.

24.

Cost analysis of three techniques of administering sevoflurane.

Tyagi A, Venkateswaran V, Jain AK, Verma UC.

Anesthesiol Res Pract. 2014;2014:459432. doi: 10.1155/2014/459432. Epub 2014 Oct 29.

25.

High temperatures result in smaller nurseries which lower reproduction of pollinators and parasites in a brood site pollination mutualism.

Krishnan A, Pramanik GK, Revadi SV, Venkateswaran V, Borges RM.

PLoS One. 2014 Dec 18;9(12):e115118. doi: 10.1371/journal.pone.0115118. eCollection 2014.

26.

Capsaicin: a novel radio-sensitizing agent for prostate cancer.

Venier NA, Colquhoun AJ, Sasaki H, Kiss A, Sugar L, Adomat H, Fleshner NE, Klotz LH, Venkateswaran V.

Prostate. 2015 Feb;75(2):113-25. doi: 10.1002/pros.22896. Epub 2014 Oct 13.

PMID:
25307418
27.

β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells.

Keerthivasan S, Aghajani K, Dose M, Molinero L, Khan MW, Venkateswaran V, Weber C, Emmanuel AO, Sun T, Bentrem DJ, Mulcahy M, Keshavarzian A, Ramos EM, Blatner N, Khazaie K, Gounari F.

Sci Transl Med. 2014 Feb 26;6(225):225ra28. doi: 10.1126/scitranslmed.3007607.

28.

Periprostatic adipose tissue and prostate cancer progression: new insights into the tumor microenvironment.

Toren P, Venkateswaran V.

Clin Genitourin Cancer. 2014 Feb;12(1):21-6. doi: 10.1016/j.clgc.2013.07.013. Epub 2013 Oct 24. Review. No abstract available.

PMID:
24269373
29.

Exercise does not counteract the effects of a "westernized" diet on prostate cancer xenografts.

Vandersluis AD, Venier NA, Colquhoun AJ, Sugar L, Pollak M, Kiss A, Fleshner NE, Klotz LH, Venkateswaran V.

Prostate. 2013 Aug;73(11):1223-32. doi: 10.1002/pros.22673. Epub 2013 Apr 30.

PMID:
23630020
30.

Diet, obesity, and cancer progression: are adipocytes the link?

Toren P, Mora BC, Venkateswaran V.

Lipid Insights. 2013 Jun 27;6:37-45. doi: 10.4137/LPI.S10871. eCollection 2013. Review.

31.

Population based study of long-term rates of surgery for urinary incontinence after radical prostatectomy for prostate cancer.

Nam RK, Herschorn S, Loblaw DA, Liu Y, Klotz LH, Carr LK, Kodama RT, Stanimirovic A, Venkateswaran V, Saskin R, Law CH, Urbach DR, Narod SA.

J Urol. 2012 Aug;188(2):502-6. doi: 10.1016/j.juro.2012.04.005. Epub 2012 Jun 15.

PMID:
22704098
32.

Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer.

Colquhoun AJ, Venier NA, Vandersluis AD, Besla R, Sugar LM, Kiss A, Fleshner NE, Pollak M, Klotz LH, Venkateswaran V.

Prostate Cancer Prostatic Dis. 2012 Dec;15(4):346-52. doi: 10.1038/pcan.2012.16. Epub 2012 May 22.

PMID:
22614062
33.

New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort.

Nam RK, Zhang W, Siminovitch K, Shlien A, Kattan MW, Klotz LH, Trachtenberg J, Lu Y, Zhang J, Yu C, Toi A, Loblaw DA, Venkateswaran V, Stanimirovic A, Sugar L, Malkin D, Seth A, Narod SA.

Cancer Biol Ther. 2011 Dec 1;12(11):997-1004. doi: 10.4161/cbt.12.11.18366. Epub 2011 Dec 1.

34.

Induction of specific human cytotoxic T cells using dendritic cells transduced with an adenovector encoding rat epidermal growth factor receptor 2.

Suresh K, Scheid E, Klotz L, Venkateswaran V, Gauldie J, Foley R.

Int J Oncol. 2011 Oct;39(4):907-13. doi: 10.3892/ijo.2011.1124. Epub 2011 Jul 14.

PMID:
21769423
35.

Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators.

Nam RK, Kattan MW, Chin JL, Trachtenberg J, Singal R, Rendon R, Klotz LH, Sugar L, Sherman C, Izawa J, Bell D, Stanimirovic A, Venkateswaran V, Diamandis EP, Yu C, Loblaw DA, Narod SA.

J Clin Oncol. 2011 Aug 1;29(22):2959-64. doi: 10.1200/JCO.2010.32.6371. Epub 2011 Jun 20.

PMID:
21690464
36.

A whole-genome SNP association study of NCI60 cell line panel indicates a role of Ca2+ signaling in selenium resistance.

Savas S, Briollais L, Ibrahim-zada I, Jarjanazi H, Choi YH, Musquera M, Fleshner N, Venkateswaran V, Ozcelik H.

PLoS One. 2010 Sep 7;5(9):e12601. doi: 10.1371/journal.pone.0012601.

37.

Finger millet (Eleusine coracana) - an economically viable source for antihypercholesterolemic metabolites production by Monascus purpureus.

Venkateswaran V, Vijayalakshmi G.

J Food Sci Technol. 2010 Aug;47(4):426-31. doi: 10.1007/s13197-010-0070-9. Epub 2010 Sep 8.

38.

Diet and prostate cancer: mechanisms of action and implications for chemoprevention.

Venkateswaran V, Klotz LH.

Nat Rev Urol. 2010 Aug;7(8):442-53. doi: 10.1038/nrurol.2010.102. Epub 2010 Jul 20. Review.

PMID:
20647991
39.

Antiproliferative mechanisms of the flavonoids 2,2'-dihydroxychalcone and fisetin in human prostate cancer cells.

Haddad AQ, Fleshner N, Nelson C, Saour B, Musquera M, Venkateswaran V, Klotz L.

Nutr Cancer. 2010;62(5):668-81. doi: 10.1080/01635581003605524.

PMID:
20574928
40.

Protective effect of metformin in CD1 mice placed on a high carbohydrate-high fat diet.

Hou M, Venier N, Sugar L, Musquera M, Pollak M, Kiss A, Fleshner N, Klotz L, Venkateswaran V.

Biochem Biophys Res Commun. 2010 Jul 2;397(3):537-42. doi: 10.1016/j.bbrc.2010.05.152. Epub 2010 Jun 2.

PMID:
20573602
41.

Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4.

Cervi D, Pak B, Venier NA, Sugar LM, Nam RK, Fleshner NE, Klotz LH, Venkateswaran V.

BMC Cancer. 2010 Jun 4;10:258. doi: 10.1186/1471-2407-10-258.

42.

Value addition to finger millet (Eleusine coracana) by germination and fermentation with Monascus purpureus.

Venkateswaran V, Vijayalakshmi G.

Int J Food Sci Nutr. 2010 Nov;61(7):722-7. doi: 10.3109/09637481003757878.

PMID:
20450382
43.

Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing?

Tabassum A, Bristow RG, Venkateswaran V.

Cancer Treat Rev. 2010 May;36(3):230-4. doi: 10.1016/j.ctrv.2009.12.008. Epub 2010 Jan 15. Review.

PMID:
20079573
44.

A combination of micronutrients is beneficial in reducing the incidence of prostate cancer and increasing survival in the Lady transgenic model.

Venkateswaran V, Klotz LH, Ramani M, Sugar LM, Jacob LE, Nam RK, Fleshner NE.

Cancer Prev Res (Phila). 2009 May;2(5):473-83. doi: 10.1158/1940-6207.CAPR-08-0124. Epub 2009 Apr 28.

45.

Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.

Kron K, Pethe V, Briollais L, Sadikovic B, Ozcelik H, Sunderji A, Venkateswaran V, Pinthus J, Fleshner N, van der Kwast T, Bapat B.

PLoS One. 2009;4(3):e4830. doi: 10.1371/journal.pone.0004830. Epub 2009 Mar 13.

46.

Utility of incorporating genetic variants for the early detection of prostate cancer.

Nam RK, Zhang WW, Trachtenberg J, Seth A, Klotz LH, Stanimirovic A, Punnen S, Venkateswaran V, Toi A, Loblaw DA, Sugar L, Siminovitch KA, Narod SA.

Clin Cancer Res. 2009 Mar 1;15(5):1787-93. doi: 10.1158/1078-0432.CCR-08-1593. Epub 2009 Feb 17.

47.

The impact of diet and micronutrient supplements on the expression of neuroendocrine markers in murine Lady transgenic prostate.

Palmer J, Venkateswaran V, Fleshner NE, Klotz LH, Cox ME.

Prostate. 2008 Mar 1;68(4):345-53. doi: 10.1002/pros.20692.

PMID:
18188867
48.

Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.

Venkateswaran V, Haddad AQ, Fleshner NE, Fan R, Sugar LM, Nam R, Klotz LH, Pollak M.

J Natl Cancer Inst. 2007 Dec 5;99(23):1793-800. Epub 2007 Nov 27.

PMID:
18042933
49.

A genome-wide association screen identifies regions on chromosomes 1q25 and 7p21 as risk loci for sporadic prostate cancer.

Nam RK, Zhang WW, Loblaw DA, Klotz LH, Trachtenberg J, Jewett MA, Stanimirovic A, Davies TO, Toi A, Venkateswaran V, Sugar L, Siminovitch KA, Narod SA.

Prostate Cancer Prostatic Dis. 2008;11(3):241-6. Epub 2007 Sep 18.

PMID:
17876339
50.

Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression.

Nam RK, Sugar L, Wang Z, Yang W, Kitching R, Klotz LH, Venkateswaran V, Narod SA, Seth A.

Cancer Biol Ther. 2007 Jan;6(1):40-5.

PMID:
17172822

Supplemental Content

Loading ...
Support Center